These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

796 related items for PubMed ID: 15346287

  • 1. [Metabolic imaging to follow stereotactic radiation of gliomas -- the role of 1H MR spectroscopy in comparison to FDG-PET and IMT-SPECT].
    Lichy MP, Henze M, Plathow C, Bachert P, Kauczor HU, Schlemmer HP.
    Rofo; 2004 Aug; 176(8):1114-21. PubMed ID: 15346287
    [Abstract] [Full Text] [Related]

  • 2. [Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].
    Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.
    Rofo; 2006 Jun; 178(6):627-33. PubMed ID: 16703499
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of diagnostic accuracy of (18)F-FDG PET, (123)I-IMT- and (99m)Tc-MIBI SPECT: evaluation of tumour progression in irradiated low grade astrocytomas].
    Henze M, Ozdemir-Sahin N, Hipp P, Mier W, Eisenhut M, Debus J, Haberkorn U.
    Nuklearmedizin; 2006 Jun; 45(1):49-56. PubMed ID: 16493514
    [Abstract] [Full Text] [Related]

  • 4. PET and SPECT for detection of tumor progression in irradiated low-grade astrocytoma: a receiver-operating-characteristic analysis.
    Henze M, Mohammed A, Schlemmer HP, Herfarth KK, Hoffner S, Haufe S, Mier W, Eisenhut M, Debus J, Haberkorn U.
    J Nucl Med; 2004 Apr; 45(4):579-86. PubMed ID: 15073253
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F]fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy.
    Bader JB, Samnick S, Moringlane JR, Feiden W, Schaefer A, Kremp S, Kirsch CM.
    Eur J Nucl Med; 1999 Feb; 26(2):144-51. PubMed ID: 9933348
    [Abstract] [Full Text] [Related]

  • 6. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M, Eisenacher J, Bruhn H, Wurm R, Michel R, Stockhammer F, Feussner A, Dudeck O, Wust P, Felix R, Amthauer H.
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [Abstract] [Full Text] [Related]

  • 7. Detection of tumour progression in the follow-up of irradiated low-grade astrocytomas: comparison of 3-[123I]iodo-alpha-methyl- L-tyrosine and 99mTc-MIBI SPET.
    Henze M, Mohammed A, Schlemmer H, Herfarth KK, Mier W, Eisenhut M, Debus J, Haberkorn U.
    Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1455-61. PubMed ID: 12397464
    [Abstract] [Full Text] [Related]

  • 8. Fluorine-18-FDG PET and iodine-123-IMT SPECT in the evaluation of brain tumors.
    Weber W, Bartenstein P, Gross MW, Kinzel D, Daschner H, Feldmann HJ, Reidel G, Ziegler SI, Lumenta C, Molls M, Schwaiger M.
    J Nucl Med; 1997 May; 38(5):802-8. PubMed ID: 9170450
    [Abstract] [Full Text] [Related]

  • 9. Reirradiation of recurrent high-grade gliomas using amino acid PET (SPECT)/CT/MRI image fusion to determine gross tumor volume for stereotactic fractionated radiotherapy.
    Grosu AL, Weber WA, Franz M, Stärk S, Piert M, Thamm R, Gumprecht H, Schwaiger M, Molls M, Nieder C.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):511-9. PubMed ID: 16168843
    [Abstract] [Full Text] [Related]

  • 10. Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Bénard F, Romsa J, Hustinx R.
    Semin Nucl Med; 2003 Apr 01; 33(2):148-62. PubMed ID: 12756647
    [Abstract] [Full Text] [Related]

  • 11. Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy.
    Knowlton RC, Laxer KD, Ende G, Hawkins RA, Wong ST, Matson GB, Rowley HA, Fein G, Weiner MW.
    Ann Neurol; 1997 Dec 01; 42(6):829-37. PubMed ID: 9403474
    [Abstract] [Full Text] [Related]

  • 12. Diagnostic accuracy of 201Thallium-SPECT and 18F-FDG-PET in the clinical assessment of glioma recurrence.
    Gómez-Río M, Rodríguez-Fernández A, Ramos-Font C, López-Ramírez E, Llamas-Elvira JM.
    Eur J Nucl Med Mol Imaging; 2008 May 01; 35(5):966-75. PubMed ID: 18172642
    [Abstract] [Full Text] [Related]

  • 13. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Weber MA, Henze M, Tüttenberg J, Stieltjes B, Meissner M, Zimmer F, Burkholder I, Kroll A, Combs SE, Vogt-Schaden M, Giesel FL, Zoubaa S, Haberkorn U, Kauczor HU, Essig M.
    Invest Radiol; 2010 Dec 01; 45(12):755-68. PubMed ID: 20829706
    [Abstract] [Full Text] [Related]

  • 14. Comparison of O-(2-18F-fluoroethyl)-L-tyrosine PET and 3-123I-iodo-alpha-methyl-L-tyrosine SPECT in brain tumors.
    Pauleit D, Floeth F, Tellmann L, Hamacher K, Hautzel H, Müller HW, Coenen HH, Langen KJ.
    J Nucl Med; 2004 Mar 01; 45(3):374-81. PubMed ID: 15001676
    [Abstract] [Full Text] [Related]

  • 15. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
    Valk PE, Budinger TF, Levin VA, Silver P, Gutin PH, Doyle WK.
    J Neurosurg; 1988 Dec 01; 69(6):830-8. PubMed ID: 2848111
    [Abstract] [Full Text] [Related]

  • 16. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.
    Invest Radiol; 2013 May 01; 48(5):295-301. PubMed ID: 23296081
    [Abstract] [Full Text] [Related]

  • 17. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
    Oriuchi N, Tomiyoshi K, Inoue T, Ahmad K, Sarwar M, Tokunaga M, Suzuki H, Watanabe N, Hirano T, Horikoshi S, Shibasaki T, Tamura M, Endo K.
    J Nucl Med; 1996 Mar 01; 37(3):457-62. PubMed ID: 8772644
    [Abstract] [Full Text] [Related]

  • 18. Differentiation between recurrent brain tumour and post-radiation necrosis: the value of 201Tl SPET versus 18F-FDG PET using a dual-headed coincidence camera--a pilot study.
    Stokkel M, Stevens H, Taphoorn M, Van Rijk P.
    Nucl Med Commun; 1999 May 01; 20(5):411-7. PubMed ID: 10404525
    [Abstract] [Full Text] [Related]

  • 19. Metabolic imaging of cerebral gliomas: spatial correlation of changes in O-(2-18F-fluoroethyl)-L-tyrosine PET and proton magnetic resonance spectroscopic imaging.
    Stadlbauer A, Prante O, Nimsky C, Salomonowitz E, Buchfelder M, Kuwert T, Linke R, Ganslandt O.
    J Nucl Med; 2008 May 01; 49(5):721-9. PubMed ID: 18413402
    [Abstract] [Full Text] [Related]

  • 20. Image-fusion of MR spectroscopic images for treatment planning of gliomas.
    Chang J, Thakur S, Perera G, Kowalski A, Huang W, Karimi S, Hunt M, Koutcher J, Fuks Z, Amols H, Narayana A.
    Med Phys; 2006 Jan 01; 33(1):32-40. PubMed ID: 16485406
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.